1-8 of 8
Weige Wang
Close
Sort by
Journal Articles

Preliminary Safety, Pharmacological and Efficacy Data from Patients with Relapsed or Refractory B-Cell Malignancies Treated with the ICP-248, a Next Generation BCL2 Inhibitor

Shuhua Yi, Jie Jin, Keshu Zhou, Huayuan Zhu, Kate Ma, Rili Jiang, Weige Wang, Bin Zhang, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6149.
https://doi.org/10.1182/blood-2023-182558
Published: 2023
Journal Articles

Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenström's Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study: Long Term Follow-up Results

Xinxin Cao, Jie Jin, Fu Cheng Cheng, Shuhua Yi, Weili Zhao, Zimin Sun, Wei Yang, Dengju Li, Guohui CUI, Jianda Hu, Ting Liu, Yongping Song, Bing Xu, Zunmin Zhu, Wei Xu, Mingzhi Zhang, Sichen Li, Weige Wang, Renbin Zhao, Daobin Zhou
Journal: Blood
Blood (2023) 142 (Supplement 1): 3039.
https://doi.org/10.1182/blood-2023-181500
Published: 2023
Journal Articles

Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory Marginal Zone Lymphoma: Initial Results of the MAGNOLIA (BGB-3111-214) Trial

Stephen Opat, FRACP, FRCPA, MBBS, Alessandra Tedeschi, MD, Kim Linton, MBChB, MRCP, PhD, Pamela McKay, MBChB (Hons), FRCP, FRCPath, Bei Hu, MD, Henry Chan, MBChB, FRACP, FRCPA, Jie Jin, MD PhD, Pier Luigi Zinzani, MD, Peter Browett, BMedSci, MBChB, FRACP, FRCPA, Morton Coleman, MD, Magdalena Sobieraj-Teague, MBBS, FRACP, FRCPA, M.Sc, Xiaoyan Ke, MD PhD, Mingyuan Sun, MD, Robert Marcus, MA, FRCP, FRCPath, Craig A. Portell, MD, Keshu Zhou, MD PhD, Catherine Thieblemont, MD PhD, Melannie Co, MD, Weige Wang, MD, Chris Tankersley, BS, Wenxiao Zhou, M.Sc, Massimo Cappellini, BS, Jane Huang, MD, Judith Trotman, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–30.
https://doi.org/10.1182/blood-2020-134611
Published: 2020
Journal Articles

Inhibition of B-Cell Receptor Signaling Disrupts Cell Adhesion in Mantle Cell Lymphoma Via RAC2

Weige Wang, MD, Franzen Carrie, Hui Guo, PhD, Jimmy Lee, MD, Yan Li, Madina Sukhanova, PhD, Dong Sheng, MD, Girish Venkataraman, MD MBBS, Ming Mei, Pin Lu, PhD, Anhui Gao, Chunmei Xia, Li Jia, Liang Zhang, MD PhD, Michael Wang, MD, Jorge Andrade, Zhou Xiaoyan, Y. Lynn Lynn Wang, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1369.
https://doi.org/10.1182/blood-2018-99-118598
Published: 2018
Journal Articles

Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin

Wei Jiang, Xiaoyan Zhou, Zengxia Li, Kaiyu Liu, Weige Wang, Renke Tan, Xiaoji Cong, Jiaoyu Shan, Yanxia Zhan, Zhaomeng Cui, Lizhi Jiang, Quanfu Li, Suqin Shen, Meirong Bai, Yunfeng Cheng, Bin Li, Minjia Tan, Dengke K. Ma, Jun O. Liu, Yongjun Dang
Journal: Blood
Blood (2018) 131 (12): 1325–1336.
https://doi.org/10.1182/blood-2017-07-794875
Published: 2018
Includes: Supplemental data
Journal Articles

XPO1 Inhibitor Selinexor Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma Via Nuclear Retention of IκB

Y. Lynn Wang, MD PhD, Mei Ming, PhD, Bingqing Xie, Madina Sukhanova, Weige Wang, MD, Sabah Kadri, PhD, Shruti Sharma, Jimmy Lee, Sharon Shacham, PhD MBA, Yosef Landesman, PhD, Natalia Maltsev, Pin Lu, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3837.
https://doi.org/10.1182/blood.V130.Suppl_1.3837.3837
Published: 2017
Journal Articles

PET-CT Invisible Diffuse Large B-Cell Lymphoma Features a Silent B-Cell Receptor Signaling

Dong Sheng, MD, Ting Li, MD, Xiangnan Jiang, MD, Weige Wang, MD, Y. Lynn Wang, MD PhD, Xiaoqiu Li
Journal: Blood
Blood (2017) 130 (Supplement 1): 2853.
https://doi.org/10.1182/blood.V130.Suppl_1.2853.2853
Published: 2017
Journal Articles

RAC2 Links B-Cell Receptor Signaling and Cell Adhesion in Mantle Cell Lymphoma

Weige Wang, Franzen Carrie, Madina Sukhanova, Venkataraman Girish, Ming Mei, Guo Ailin, Pin Lu, PhD, Dong Sheng, MD, Gao Anhui, Xia Chunmei, Li Jia, Zhou Xiaoyan, Y Lynn Wang
Journal: Blood
Blood (2017) 130 (Supplement 1): 2752.
https://doi.org/10.1182/blood.V130.Suppl_1.2752.2752
Published: 2017